Metraipolis › archive › dc_bbb2947134eb

Third-Generation Antipsychotics as Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder: A Narrative Review of Efficacy and Tolerability — Europe PMC PMID:41595713

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41595713
DOI
10.3390/biomedicines14010179
License (as archived)
solo-consultazione
Archived
2026-11-06T19:31:15.606Z
SHA-256 of the archived text
30d37806b5acdd103d2567fec47b5f7e1525cc772298e69cfe4b422705fa4cd3
Stable URL of this page
https://metraipolis.com/documento/dc_bbb2947134eb

How to cite

Third-Generation Antipsychotics as Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder: A Narrative Review of Efficacy and Tolerability — Europe PMC PMID:41595713 — Europe PMC (en), https://europepmc.org/article/MED/41595713 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bbb2947134eb (Metraipolis archive dc_bbb2947134eb, sha256 30d37806b5acdd103d2567fec47b5f7e1525cc772298e69cfe4b422705fa4cd3)
BibTeX
@misc{dcbbb2947134eb,
  title = {Third-Generation Antipsychotics as Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder: A Narrative Review of Efficacy and Tolerability — Europe PMC PMID:41595713},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41595713},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bbb2947134eb; sha256 30d37806b5acdd103d2567fec47b5f7e1525cc772298e69cfe4b422705fa4cd3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41595713. Agents can read the archived copy with the MCP tool read_document.